Emami in talks to buy Paras Pharma; deal may cost Rs. 4,000 cr

Emami Ltd is in negotiations to acquire a controlling stake in unlisted Paras Pharmaceuticals Ltd for consideration of Rs 4,000 crore. Paras have over-the-counter (OTC) and personal care product brands such as Moov, Krack, Set Wet, D’Cold and RingGuard in its fold.

Two private equity firms, Actis Advisors Pvt. Ltd and Sequoia Capital India Advisors Pvt. Ltd, which jointly hold around 70% in Paras, have been looking to sell their stake in the company for around $700 million (Rs.3,269 crore), The remaining 30% stake in the firm is held by chairman and original promoter Girish Patel.

Emami had Rs.604 crore of cash reserves on its balance sheet as on 31 March and had passed an enabling resolution to raise Rs.1000 crore in June.